Induced Pluripotent Stem Cell Trends and Forecast
The future of the global induced pluripotent stem cell market looks promising with opportunities in the research & academic institute, biotechnology & pharmaceutical company, and hospital & clinic markets. The global induced pluripotent stem cell market is expected to reach an estimated $2.6 billion by 2030 with a CAGR of 10.3% from 2024 to 2030. The major drivers for this market are rising prevalence of cancer, amplified financial investments in stem cell research, and the numerous benefits of induced pluripotent stem cells (iPSCs) compared to embryonic stem cells (ESCs).A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Induced Pluripotent Stem Cell by Segment
The study includes a forecast for the global induced pluripotent stem cell by workflow, application, end use, and region.Induced Pluripotent Stem Cell Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:
- Reprogramming
- Cell Culture
- Cell Characterization / Analysis
- Engineering
- Others
Induced Pluripotent Stem Cell Market by Application [Shipment Analysis by Value from 2018 to 2030]:
- Drug Development & Discovery
- Regenerative Medicine
- Toxicology Studies
- Others
Induced Pluripotent Stem Cell Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
- Research & Academic Institutes
- Biotechnology & Pharmaceutical Companies
- Hospitals & Clinics
Induced Pluripotent Stem Cell Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Induced Pluripotent Stem Cell Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies induced pluripotent stem cell companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the induced pluripotent stem cell companies profiled in this report include-- Lonza
- Axol Bioscience
- Evotec
- Hitachi
- Reprocell
- Merck
- Reprocells
- Fate Therapeutics
- Thermo Fisher Scientific
- Stemcellsfactory III
Induced Pluripotent Stem Cell Market Insights
The publisher forecasts that drug development & discovery will remain the largest segment over the forecast period because the chronic illnesses are spreading throughout the world.APAC is expected to witness fastest growth over the forecast period due to robust, cost-effective focus on stem cell-based research, the expansion of economies, improvements in healthcare strategies, and the increasing recognition of the promise of personalized treatments.
Features of the Global Induced Pluripotent Stem Cell Market
- Market Size Estimates: Induced pluripotent stem cell market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: Induced pluripotent stem cell market size by workflow, application, end use, and region in terms of value ($B).
- Regional Analysis: Induced pluripotent stem cell market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different workflow, application, end use, and regions for the induced pluripotent stem cell market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the induced pluripotent stem cell market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the induced pluripotent stem cell market size?Answer: The global induced pluripotent stem cell market is expected to reach an estimated $2.6 billion by 2030.
Q.2 What is the growth forecast for induced pluripotent stem cell market?
Answer: The global induced pluripotent stem cell market is expected to grow with a CAGR of 10.3% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the induced pluripotent stem cell market?
Answer: The major drivers for this market are rising prevalence of cancer, amplified financial investments in stem cell research, and the numerous benefits of induced pluripotent stem cells (iPSCs) compared to embryonic stem cells (ESCs).
Q4. What are the major segments for induced pluripotent stem cell market?
Answer: The future of the global induced pluripotent stem cell market looks promising with opportunities in the research & academic institute, biotechnology & pharmaceutical company, and hospital & clinic markets.
Q5. Who are the key induced pluripotent stem cell market companies?
Answer: Some of the key induced pluripotent stem cell companies are as follows:
- Lonza
- Axol Bioscience
- Evotec
- Hitachi
- Reprocell
- Merck
- Reprocells
- Fate Therapeutics
- Thermo Fisher Scientific
- Stemcellsfactory III
Answer: The publisher forecasts that drug development & discovery will remain the largest segment over the forecast period because the chronic illnesses are spreading throughout the world.
Q7. In induced pluripotent stem cell market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness fastest growth over the forecast period due to robust, cost-effective focus on stem cell-based research, the expansion of economies, improvements in healthcare strategies, and the increasing recognition of the promise of personalized treatments.
Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the induced pluripotent stem cell market by workflow (reprogramming, cell culture, cell characterization / analysis, engineering, and others), application (drug development & discovery, regenerative medicine, toxicology studies, and others), end use (research & academic institutes, biotechnology & pharmaceutical companies, and hospitals & clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global Induced Pluripotent Stem Cell Market : Market Dynamics
3. Market Trends and Forecast Analysis from 2018 to 2030
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Lonza
- Axol Bioscience
- Evotec
- Hitachi
- Reprocell
- Merck
- Reprocells
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
